Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
August-2018 Volume 42 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2018 Volume 42 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

MicroRNA‑381/Hes1 is a potential therapeutic target for spinal cord injury

  • Authors:
    • Wendong Ruan
    • Guangzhi Ning
    • Shiqing Feng
    • Shijie Gao
    • Yan Hao
  • View Affiliations / Copyright

    Affiliations: Department of Orthopedics, The General Hospital of Tianjin Medical University, Heping, Tianjin 300052, P.R. China
  • Pages: 1008-1017
    |
    Published online on: May 8, 2018
       https://doi.org/10.3892/ijmm.2018.3658
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to investigate whether microRNA‑381 is a potential therapeutic target for spinal cord injury (SCI) and its possible mechanism. Reverse transcription quantitative polymerase chain reaction (qPCR) for mRNA expression was used to analyze the changes of microRNA-381 expression. Cell viability and cell apoptosis were measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry. Caspase‑3 activity was measured using caspase‑3 activity kit, and western blot analysis was used to measure the protein expression of neurogenic locus notch homolog protein 1 (Notch1), notch 1 intracellular domain (NICD) and transcription factor HES-1 (Hes1). The data showed that microRNA‑381 expression of model SCI rats was downregulated compared with that of control rats. Overexpression of microRNA‑381 promoted cell proliferation, and inhibited apoptosis and caspase‑3 and apoptosis regulator BAX (Bax) protein expression in neurocytes. Overexpression of microRNA‑381 also increased Wnt and β‑catenin protein expression, and suppressed the protein expression of Notch1, NICD and Hes1 in neurocytes. Wnt inhibitor, Wnt‑C59 (1 µmol/l), inhibited cell proliferation, promoted apoptosis and caspase‑3 and Bax protein expression, suppressed β‑catenin protein expression and induced Hes1 protein expression in neurocytes following microRNA‑381 overexpression. Notch inhibitor, FLI‑06 (1 µmol/l), promoted cell proliferation, inhibited apoptosis and caspase‑3 and Bax protein expression, and suppressed NICD and Hes1 protein expression in neurocytes following microRNA‑381 overexpression. Thus, this study showed that overexpression of microRNA‑381 promotes cell proliferation of neurocytes in SCI via Hes1 expression, which may be a novel important mechanism for SCI in clinical applications.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

Figure 10

Figure 11

Figure 12

Figure 13

Figure 14

Figure 15

View References

1 

Wecht JM, Weir JP, Radulovic M and Bauman WA: Effects of midodrine and L-NAME on systemic and cerebral hemodynamics during cognitive activation in spinal cord injury and intact controls. Physiol Rep. 4:e12682016. View Article : Google Scholar

2 

Ziu M, Fletcher L, Savage JG, Jimenez DF, Digicaylioglu M and Bartanusz V: Spatial and temporal expression levels of specific microRNAs in a spinal cord injury mouse model and their relationship to the duration of compression. Spine J. 14:353–360. 2014. View Article : Google Scholar

3 

Shin JC, Kim KN, Yoo J, Kim IS, Yun S, Lee H, Jung K, Hwang K, Kim M, Lee IS, et al: Clinical trial of human fetal brain-derived neural stem/progenitor cell transplantation in patients with traumatic cervical spinal cord injury. Neural Plast. 2015:6309322015. View Article : Google Scholar : PubMed/NCBI

4 

Evans CT, Hill JN, Guihan M, Chin A, Goldstein B, Richardson MS, Anderson V, Risa K, Kellie S and Cameron KA: Implementing a patient education intervention about methicillin-resistant Staphylococcus aureus prevention and effect on knowledge and behavior in veterans with spinal cord injuries and disorders: A pilot randomized controlled trial. J Spinal Cord Med. 37:152–161. 2014. View Article : Google Scholar :

5 

Karthikeyan A, Patnala R, Jadhav SP, Eng-Ang L and Dheen ST: MicroRNAs: Key players in microglia and astrocyte mediated inflammation in CNS pathologies. Curr Med Chem. 23:3528–3546. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Hachisuka S, Kamei N, Ujigo S, Miyaki S, Yasunaga Y and Ochi M: Circulating microRNAs as biomarkers for evaluating the severity of acute spinal cord injury. Spinal Cord. 52:596–600. 2014. View Article : Google Scholar : PubMed/NCBI

7 

Yan H, Hong P, Jiang M and Li H: MicroRNAs as potential therapeutics for treating spinal cord injury. Neural Regen Res. 7:1352–1359. 2012.PubMed/NCBI

8 

Strickland ER, Woller SA, Garraway SM, Hook MA, Grau JW and Miranda RC: Regulatory effects of intermittent noxious stimulation on spinal cord injury-sensitive microRNAs and their presumptive targets following spinal cord contusion. Front Neural Circuits. 8:1172014. View Article : Google Scholar : PubMed/NCBI

9 

Zhou S, Ding F and Gu X: Non-coding RNAs as emerging regulators of neural injury responses and regeneration. Neurosci Bull. 32:253–264. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Kang SK, Yeo JE, Kang KS and Phinney DG: Cytoplasmic extracts from adipose tissue stromal cells alleviates secondary damage by modulating apoptosis and promotes functional recovery following spinal cord injury. Brain Pathol. 17:263–275. 2007. View Article : Google Scholar : PubMed/NCBI

11 

Dhanesh SB, Subashini C and James J: Hes1: The maestro in neurogenesis. Cell Mol Life Sci. 73:4019–4042. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Sang L, Roberts JM and Coller HA: Hijacking HES1: How tumors co-opt the anti-differentiation strategies of quiescent cells. Trends Mol Med. 16:17–26. 2010. View Article : Google Scholar

13 

Aujla PK, Bora A, Monahan P, Sweedler JV and Raetzman LT: The Notch effector gene Hes1 regulates migration of hypothalamic neurons, neuropeptide content and axon targeting to the pituitary. Dev Biol. 353:61–71. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Ingram WJ, McCue KI, Tran TH, Hallahan AR and Wainwright BJ: Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling. Oncogene. 27:1489–1500. 2008. View Article : Google Scholar

15 

Baek JH, Hatakeyama J, Sakamoto S, Ohtsuka T and Kageyama R: Persistent and high levels of Hes1 expression regulate boundary formation in the developing central nervous system. Development. 133:2467–2476. 2006. View Article : Google Scholar : PubMed/NCBI

16 

Goto M, Hojo M, Ando M, Kita A, Kitagawa M, Ohtsuka T, Kageyama R and Miyamoto S: Hes1 and Hes5 are required for differentiation of pituicytes and formation of the neurohypophysis in pituitary development. Brain Res. 1625:206–217. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Feng S, Liu W, Zuo S, Xie T, Deng H, Zhang Q and Zhong B: Impaired function of the intestinal barrier in a novel sub-health rat model. Mol Med Rep. 13:3459–3465. 2016. View Article : Google Scholar : PubMed/NCBI

18 

Min K, Oh Y, Lee SH and Ryu JS: Symptom-based treatment of neuropathic pain in spinal cord-injured patients: A randomized crossover clinical trial. Am J Phys Med Rehabil. 95:330–338. 2016.

19 

Ellis AG, Zeglinski PT, Brown DJ, Frauman AG, Millard M and Furness JB: Pharmacokinetics of the ghrelin agonist capromorelin in a single ascending dose Phase-I safety trial in spinal cord-injured and able-bodied volunteers. Spinal Cord. 53:103–108. 2015. View Article : Google Scholar

20 

Strickland ER, Woller SA, Hook MA, Grau JW and Miranda RC: The association between spinal cord trauma-sensitive miRNAs and pain sensitivity, and their regulation by morphine. Neurochem Int. 77:40–49. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Guo ZP, Huang MN, Liu AQ, Yuan YJ, Zhao JB and Mei XF: Buyang Huanwu decoction up-regulates Notch1 gene expression in injured spinal cord. Neural Regen Res. 10:1321–1323. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Chen N, Cen JS, Wang J, Qin G, Long L, Wang L, Wei F, Xiang Q, Deng DY and Wan Y: Targeted inhibition of leucine-rich repeat and immunoglobulin domain-containing protein 1 in transplanted neural stem cells promotes neuronal differentiation and functional recovery in rats subjected to spinal cord injury. Crit Care Med. 44:e146–e157. 2016. View Article : Google Scholar

23 

Zhou QZ, Zhang G, Long HB, Lei F, Ye F, Jia XF, Zhou YL, Kang JP and Feng DX: Effect of spinal cord extracts after spinal cord injury on proliferation of rat embryonic neural stem cells and Notch signal pathway in vitro. Asian Pac J Trop Med. 7:562–567. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Geng X, Sun T, Li JH, Zhao N, Wang Y and Yu HL: Electroacupuncture in the repair of spinal cord injury: Inhibiting the Notch signaling pathway and promoting neural stem cell proliferation. Neural Regen Res. 10:394–403. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Tural Emon S, Uslu S, Ilgaz Aydinlar E, Irban A, Ince U, Orakdogen M and Gulec-Suyen G: Effects of ozone on spinal cord recovery via Wnt/β-catenin pathway following spinal cord injury in rats. Turk Neurosurg. May 5–2016.Epub ahead of print. View Article : Google Scholar

26 

Yang Z, Wu Y, Zheng L, Zhang C, Yang J, Shi M, Feng D, Wu Z and Wang YZ: Conditioned medium of Wnt/β-catenin signaling-activated olfactory ensheathing cells promotes synaptogenesis and neurite growth in vitro. Cell Mol Neurobiol. 33:983–990. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Briona LK, Poulain FE, Mosimann C and Dorsky RI: Wnt/β-catenin signaling is required for radial glial neurogenesis following spinal cord injury. Dev Biol. 403:15–21. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Strand NS, Hoi KK, Phan TM, Ray CA, Berndt JD and Moon RT: Wnt/β-catenin signaling promotes regeneration after adult zebrafish spinal cord injury. Biochem Biophys Res Commun. 477:952–956. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Zhang Q, Zhao S, Pang X and Chi B: MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma. Oncol Rep. 35:1831–1840. 2016. View Article : Google Scholar

30 

Shi Y, Shu B, Yang R, Xu Y, Xing B, Liu J, Chen L, Qi S, Liu X, Wang P, et al: Wnt and Notch signaling pathway involved in wound healing by targeting c-Myc and Hes1 separately. Stem Cell Res Ther. 6:1202015. View Article : Google Scholar : PubMed/NCBI

31 

Dakubo GD, Mazerolle CJ and Wallace VA: Expression of Notch and Wnt pathway components and activation of Notch signaling in medulloblastomas from heterozygous patched mice. J Neurooncol. 79:221–227. 2006. View Article : Google Scholar : PubMed/NCBI

32 

Gui X, Meng Z, McConnell YJ, Liu S, Falck VG, Mack LA and Temple WJ: Differing expression profiles of Notch/enterocyte and Wnt/secretory lineage signallings are associated with morphological diversity of appendiceal tumours. J Clin Pathol. 70:40–50. 2017. View Article : Google Scholar

33 

Shi X, Yan C, Liu B, Yang C, Nie X, Wang X, Zheng J, Wang Y and Zhu Y: miR-381 regulates neural stem cell proliferation and differentiation via regulating Hes1 expression. PLoS One. 10:e01389732015. View Article : Google Scholar : PubMed/NCBI

34 

Wang W, Wang P, Li S, Yang J, Liang X, Tang Y, Li Y, Yang R, Wu Y and Shen H: Methylprednisolone inhibits the proliferation and affects the differentiation of rat spinal cord-derived neural progenitor cells cultured in low oxygen conditions by inhibiting HIF-1α and Hes1 in vitro. Int J Mol Med. 34:788–795. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ruan W, Ning G, Feng S, Gao S and Hao Y: MicroRNA‑381/Hes1 is a potential therapeutic target for spinal cord injury. Int J Mol Med 42: 1008-1017, 2018.
APA
Ruan, W., Ning, G., Feng, S., Gao, S., & Hao, Y. (2018). MicroRNA‑381/Hes1 is a potential therapeutic target for spinal cord injury. International Journal of Molecular Medicine, 42, 1008-1017. https://doi.org/10.3892/ijmm.2018.3658
MLA
Ruan, W., Ning, G., Feng, S., Gao, S., Hao, Y."MicroRNA‑381/Hes1 is a potential therapeutic target for spinal cord injury". International Journal of Molecular Medicine 42.2 (2018): 1008-1017.
Chicago
Ruan, W., Ning, G., Feng, S., Gao, S., Hao, Y."MicroRNA‑381/Hes1 is a potential therapeutic target for spinal cord injury". International Journal of Molecular Medicine 42, no. 2 (2018): 1008-1017. https://doi.org/10.3892/ijmm.2018.3658
Copy and paste a formatted citation
x
Spandidos Publications style
Ruan W, Ning G, Feng S, Gao S and Hao Y: MicroRNA‑381/Hes1 is a potential therapeutic target for spinal cord injury. Int J Mol Med 42: 1008-1017, 2018.
APA
Ruan, W., Ning, G., Feng, S., Gao, S., & Hao, Y. (2018). MicroRNA‑381/Hes1 is a potential therapeutic target for spinal cord injury. International Journal of Molecular Medicine, 42, 1008-1017. https://doi.org/10.3892/ijmm.2018.3658
MLA
Ruan, W., Ning, G., Feng, S., Gao, S., Hao, Y."MicroRNA‑381/Hes1 is a potential therapeutic target for spinal cord injury". International Journal of Molecular Medicine 42.2 (2018): 1008-1017.
Chicago
Ruan, W., Ning, G., Feng, S., Gao, S., Hao, Y."MicroRNA‑381/Hes1 is a potential therapeutic target for spinal cord injury". International Journal of Molecular Medicine 42, no. 2 (2018): 1008-1017. https://doi.org/10.3892/ijmm.2018.3658
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team